{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:36Z","timestamp":1792788036707,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Natural Science Foundation","award":["Grant\u30002023GXNSFAA026012"],"award-info":[{"award-number":["Grant\u30002023GXNSFAA026012"]}]},{"name":"Guangxi Scientific and Technological Key Project","award":["Grant No. GuikeAD23026340"],"award-info":[{"award-number":["Grant No. GuikeAD23026340"]}]},{"name":"National Natural Science Foundation of China","award":["Grant No. 82460658"],"award-info":[{"award-number":["Grant No. 82460658"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Guangxi Bagui Young Top Scholar","award":["To Bingyu Liang"],"award-info":[{"award-number":["To Bingyu Liang"]}]},{"name":"Thousands of Young and Middle Age Key Teachers Training Program in Guangxi Colleges and Universities","award":["To Bingyu Liang"],"award-info":[{"award-number":["To Bingyu Liang"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-026-00911-3","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:56:08Z","timestamp":1782748568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of HIV-1 low-level viremia on virologic and immunologic failure during antiretroviral therapy: a retrospective cohort study from 2005 to 2023 in Qinzhou City, Guangxi, China"],"prefix":"10.1186","volume":"23","author":[{"given":"Long-yu","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-fu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-xing","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-jia","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-yue","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-yuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-song","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-jian","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"911_CR1","unstructured":"UNAIDS. The urgency of now: AIDS at a crossroads. 2024. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2024-unaids-global-aids-update_en.pdf. Accessed 20 Dec 2025."},{"key":"911_CR2","unstructured":"Adolescents PoAGfAa. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. 2025. https:\/\/clinicalinfo.hiv.gov\/sites\/default\/files\/guidelines\/documents\/adult-adolescent-arv\/guidelines-adult-adolescent-arv.pdf. Accessed 20 Dec 2025."},{"issue":"23","key":"911_CR3","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1097\/CM9.0000000000001226","volume":"133","author":"RJ Bai","year":"2020","unstructured":"Bai RJ, Dai LL, Wu H. Advances and challenges in antiretroviral therapy for acquired immunodeficiency syndrome. Chin Med J (Engl). 2020;133(23):2775\u20137.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"911_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tips.2021.10.004","volume":"43","author":"L Men\u00e9ndez-Arias","year":"2022","unstructured":"Men\u00e9ndez-Arias L, Delgado R. Update and latest advances in antiretroviral therapy. Trends Pharmacol Sci. 2022;43(1):16\u201329.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"911_CR5","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1080\/21505594.2021.2004743","volume":"12","author":"C Crespo-Bermejo","year":"2021","unstructured":"Crespo-Bermejo C, de Arellano ER, Lara-Aguilar V, Valle-Millares D, G\u00f3mez-Lus ML, Madrid R, Mart\u00edn-Carbonero L, Briz V. Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status. Virulence. 2021;12(1):2919\u201331.","journal-title":"Virulence"},{"issue":"13","key":"911_CR6","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1097\/QAD.0000000000003672","volume":"37","author":"HM Chun","year":"2023","unstructured":"Chun HM, Milligan K, Boyd MA, Abutu A, Bachanas P, Dirlikov E. Reaching HIV epidemic control in Nigeria using a lower HIV viral load suppression cut-off. Aids. 2023;37(13):2081\u20135.","journal-title":"Aids"},{"key":"911_CR7","unstructured":"WHO. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. 2021 https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/ad80ecdc-e3b1-4efe-b081-2877215791c5\/content. Accessed 20 Dec 2025."},{"issue":"12","key":"911_CR8","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1093\/cid\/ciaa413","volume":"72","author":"O Elvstam","year":"2021","unstructured":"Elvstam O, Marrone G, Medstrand P, Treutiger CJ, S\u00f6nnerborg A, Gissl\u00e9n M, Bj\u00f6rkman P. All-Cause Mortality and Serious Non-AIDS Events in Adults With Low-level Human Immunodeficiency Virus Viremia During Combination Antiretroviral Therapy: Results From a Swedish Nationwide Observational Study. Clin Infect Dis. 2021;72(12):2079\u201386.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"911_CR9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S1473-3099(17)30681-3","volume":"18","author":"LE Hermans","year":"2018","unstructured":"Hermans LE, Moorhouse M, Carmona S, Grobbee DE, Hofstra LM, Richman DD, Tempelman HA, Venter WDF, Wensing AMJ. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2018;18(2):188\u201397.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"911_CR10","doi-asserted-by":"publisher","first-page":"e1815","DOI":"10.1016\/S2214-109X(22)00413-2","volume":"10","author":"HM Chun","year":"2022","unstructured":"Chun HM, Abutu A, Milligan K, Ehoche A, Shiraishi RW, Odafe S, Dalhatu I, Onotu D, Okoye M, Oladipo A, et al. Low-level viraemia among people living with HIV in Nigeria: a retrospective longitudinal cohort study. Lancet Glob Health. 2022;10(12):e1815\u201324.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"911_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/QAI.0000000000001678","volume":"78","author":"E Bernal","year":"2018","unstructured":"Bernal E, G\u00f3mez JM, Jarr\u00edn I, Cano A, Mu\u00f1oz A, Alcaraz A, Imaz A, Iribarren JA, Rivero M, Arazo P, et al. Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment. J Acquir Immune Defic Syndr. 2018;78(3):329\u201337.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"911_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/QAD.0000000000000544","volume":"29","author":"MA Vandenhende","year":"2015","unstructured":"Vandenhende MA, Ingle S, May M, Chene G, Zangerle R, Van Sighem A, Gill MJ, Schwarze-Zander C, Hernandez-Novoa B, Obel N, et al. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients. Aids. 2015;29(3):373\u201383.","journal-title":"Aids"},{"key":"911_CR13","doi-asserted-by":"publisher","first-page":"939261","DOI":"10.3389\/fmed.2022.939261","volume":"9","author":"J An","year":"2022","unstructured":"An J, Lao Y, Tang S, Lou J, Li T, Dong X. The Impact of Low-Level Viraemia on Virological Failure-Results From a Multicenter HIV Antiretroviral Therapy Cohort Study in Yunnan, China. Front Med (Lausanne). 2022;9:939261.","journal-title":"Front Med (Lausanne)"},{"key":"911_CR14","doi-asserted-by":"publisher","first-page":"102166","DOI":"10.1016\/j.eclinm.2023.102166","volume":"63","author":"A Aoko","year":"2023","unstructured":"Aoko A, Pals S, Ngugi T, Katiku E, Joseph R, Basiye F, Kimanga D, Kimani M, Masamaro K, Ngugi E, et al. Retrospective longitudinal analysis of low-level viremia among HIV-1 infected adults on antiretroviral therapy in Kenya. EClinicalMedicine. 2023;63:102166.","journal-title":"EClinicalMedicine"},{"issue":"1","key":"911_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/cid\/ciac762","volume":"76","author":"O Elvstam","year":"2023","unstructured":"Elvstam O, Malmborn K, El\u00e9n S, Marrone G, Garc\u00eda F, Zazzi M, S\u00f6nnerborg A, B\u00f6hm M, Seguin-Devaux C, Bj\u00f6rkman P. Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort. Clin Infect Dis. 2023;76(1):25\u201331.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"911_CR16","doi-asserted-by":"publisher","first-page":"2447613","DOI":"10.1080\/22221751.2024.2447613","volume":"14","author":"S Zhao","year":"2025","unstructured":"Zhao S, Wang W, Li S, He J, Duan W, Fang Z, Ma X, Li Z, Guo C, Wang W, et al. The prevalence of low-level viraemia and its association with virological failure in people living with HIV: a systematic review and meta-analysis. Emerg Microbes Infect. 2025;14(1):2447613.","journal-title":"Emerg Microbes Infect"},{"key":"911_CR17","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2016. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/b5c72be6-c401-4fa6-9b64-e5f1191a88a2\/content. Accessed 20 December 2025."},{"key":"911_CR18","unstructured":"WHO. Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. 2010 https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44379\/9789241599764_eng.pdf?sequence=1. Accessed 20 December 2025."},{"issue":"21","key":"911_CR19","doi-asserted-by":"publisher","first-page":"5582","DOI":"10.1182\/blood-2010-12-322453","volume":"117","author":"P Corbeau","year":"2011","unstructured":"Corbeau P, Reynes J. Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection. Blood. 2011;117(21):5582\u201390.","journal-title":"Blood"},{"issue":"7","key":"911_CR20","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/00002030-200404300-00005","volume":"18","author":"AC Karlsson","year":"2004","unstructured":"Karlsson AC, Younger SR, Martin JN, Grossman Z, Sinclair E, Hunt PW, Hagos E, Nixon DF, Deeks SG. Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia. Aids. 2004;18(7):981\u20139.","journal-title":"Aids"},{"issue":"3","key":"911_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1086\/427340","volume":"191","author":"SR Ostrowski","year":"2005","unstructured":"Ostrowski SR, Katzenstein TL, Thim PT, Pedersen BK, Gerstoft J, Ullum H. Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy. J Infect Dis. 2005;191(3):348\u201357.","journal-title":"J Infect Dis"},{"issue":"12","key":"911_CR22","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1097\/JCMA.0000000000000812","volume":"85","author":"CT Lee","year":"2022","unstructured":"Lee CT, Chen HP, Lin HH, Ke MY, Wu PF. The influence of low-level viremia on CD4\u2009+\u2009cell count in human immunodeficiency virus-infected patients. J Chin Med Assoc. 2022;85(12):1126\u201330.","journal-title":"J Chin Med Assoc"},{"issue":"1","key":"911_CR23","doi-asserted-by":"publisher","first-page":"2429622","DOI":"10.1080\/22221751.2024.2429622","volume":"13","author":"J He","year":"2024","unstructured":"He J, Zhong S, Qin C, Nong A, Lin Z, Liang H, Zhang F, Jiang J, Pan P, Wei W, et al. The trend, prevalence and potential risk factors of secondary HIV transmission among HIV\/AIDS individuals receiving ART in Guangxi, China: a longitudinal cross-sectional study. Emerg Microbes Infect. 2024;13(1):2429622.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"911_CR24","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1186\/s12889-025-22871-5","volume":"25","author":"Y Lin","year":"2025","unstructured":"Lin Y, Chen G, Lu H, Qin R, Jiang J, Tan W, Luo C, Chen M, Huang Q, Huang L, et al. Inequality and heterogeneity in medical resources for children with autism spectrum disorders: a study in the ethnic minority region of southern China. BMC Public Health. 2025;25(1):1677.","journal-title":"BMC Public Health"},{"issue":"1","key":"911_CR25","doi-asserted-by":"publisher","first-page":"2147023","DOI":"10.1080\/22221751.2022.2147023","volume":"12","author":"F Zhang","year":"2023","unstructured":"Zhang F, Yang Y, Liang N, Liang H, Chen Y, Lin Z, Chen T, Tan W, Yang Y, Huang R, et al. Transmission network and phylogenetic analysis reveal older male-centered transmission of CRF01_AE and CRF07_BC in Guangxi, China. Emerg Microbes Infect. 2023;12(1):2147023.","journal-title":"Emerg Microbes Infect"},{"key":"911_CR26","unstructured":"[Chinese guidelines for diagnosis and treatment of HIV\/AIDS. (2018)]. Zhonghua Nei Ke Za Zhi 2018, 57(12):867\u2013884."},{"key":"911_CR27","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach, 2nd ed. 2016. https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/b5c72be6-c401-4fa6-9b64-e5f1191a88a2\/content. Accessed 20 Dec 2025."},{"issue":"8","key":"911_CR28","doi-asserted-by":"publisher","first-page":"e10169","DOI":"10.1016\/j.heliyon.2022.e10169","volume":"8","author":"T Kiros","year":"2022","unstructured":"Kiros T, Taye A, Workineh L, Eyayu T, Damtie S, Hailemichael W, Tiruneh T. Immuno-virological status and its associated factors among HIV-positive patients receiving highly active antiretroviral therapy at delgi primary hospital, northwest Ethiopia, 2020\/2021: A cross-sectional study. Heliyon. 2022;8(8):e10169.","journal-title":"Heliyon"},{"issue":"5","key":"911_CR29","doi-asserted-by":"publisher","first-page":"e0284405","DOI":"10.1371\/journal.pone.0284405","volume":"18","author":"D Niu","year":"2023","unstructured":"Niu D, Tang H, Chen F, Zhao D, Zhao H, Hou Y, Wang S, Lyu F. Treatment failure and associated factors among people living with HIV on highly active antiretroviral therapy in mainland China: A systematic review and meta-analysis. PLoS ONE. 2023;18(5):e0284405.","journal-title":"PLoS ONE"},{"issue":"1","key":"911_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40249-023-01119-7","volume":"12","author":"X Wu","year":"2023","unstructured":"Wu X, Wu G, Ma P, Wang R, Li L, Sun Y, Xu J, Li Y, Zhang T, Li Q, et al. Immediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis. Infect Dis Poverty. 2023;12(1):73.","journal-title":"Infect Dis Poverty"},{"key":"911_CR31","doi-asserted-by":"publisher","first-page":"1451201","DOI":"10.3389\/fmicb.2024.1451201","volume":"15","author":"W Zhang","year":"2024","unstructured":"Zhang W, Shi J, Wang Y, Li E, Yan D, Zhang Z, Zhu M, Yu J, Wang Y. Risk factors and clinical prediction models for low-level viremia in people living with HIV receiving antiretroviral therapy: an 11-year retrospective study. Front Microbiol. 2024;15:1451201.","journal-title":"Front Microbiol"},{"issue":"5","key":"911_CR32","doi-asserted-by":"publisher","first-page":"e36673","DOI":"10.1371\/journal.pone.0036673","volume":"7","author":"C Delaugerre","year":"2012","unstructured":"Delaugerre C, Gallien S, Flandre P, Mathez D, Amarsy R, Ferret S, Timsit J, Molina JM, de Truchis P. Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients. PLoS ONE. 2012;7(5):e36673.","journal-title":"PLoS ONE"},{"issue":"8","key":"911_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/cid\/ciu019","volume":"58","author":"A Gonzalez-Serna","year":"2014","unstructured":"Gonzalez-Serna A, Min JE, Woods C, Chan D, Lima VD, Montaner JS, Harrigan PR, Swenson LC. Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals. Clin Infect Dis. 2014;58(8):1165\u201373.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"911_CR34","doi-asserted-by":"publisher","first-page":"e0142923","DOI":"10.1371\/journal.pone.0142923","volume":"10","author":"G Leierer","year":"2015","unstructured":"Leierer G, Grabmeier-Pfistershammer K, Steuer A, Geit M, Sarcletti M, Haas B, Kanatschnig M, Rappold M, Zangerle R, Ledergerber B, et al. Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study. PLoS ONE. 2015;10(11):e0142923.","journal-title":"PLoS ONE"},{"issue":"7","key":"911_CR35","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jama.293.7.817","volume":"293","author":"RE Nettles","year":"2005","unstructured":"Nettles RE, Kieffer TL, Kwon P, Monie D, Han Y, Parsons T, Cofrancesco J Jr., Gallant JE, Quinn TC, Jackson B, et al. Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. JAMA. 2005;293(7):817\u201329.","journal-title":"JAMA"},{"issue":"11","key":"911_CR36","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1086\/498025","volume":"41","author":"V Stosor","year":"2005","unstructured":"Stosor V, Palella FJ Jr., Berzins B, Till M, Leake A, Chmiel JS, Murphy RL. Transient viremia in HIV-infected patients and use of plasma preparation tubes. Clin Infect Dis. 2005;41(11):1671\u20134.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"911_CR37","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/cid\/ciz129","volume":"69","author":"C Joya","year":"2019","unstructured":"Joya C, Won SH, Schofield C, Lalani T, Maves RC, Kronmann K, Deiss R, Okulicz J, Agan BK, Ganesan A. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure. Clin Infect Dis. 2019;69(12):2145\u201352.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"911_CR38","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/QAD.0000000000000203","volume":"28","author":"LC Swenson","year":"2014","unstructured":"Swenson LC, Min JE, Woods CK, Cai E, Li JZ, Montaner JS, Harrigan PR, Gonzalez-Serna A. HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure. Aids. 2014;28(8):1125\u201334.","journal-title":"Aids"},{"key":"911_CR39","first-page":"91","volume":"8","author":"F Maggiolo","year":"2017","unstructured":"Maggiolo F, Di Filippo E, Comi L, Callegaro A, Colombo GL, Di Matteo S, Valsecchi D, Rizzi M. Reduced adherence to antiretroviral therapy is associated with residual low-level viremia. Pragmat Obs Res. 2017;8:91\u20137.","journal-title":"Pragmat Obs Res"},{"issue":"7","key":"911_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/sextrans-2024-056199","volume":"100","author":"LV Rindi","year":"2024","unstructured":"Rindi LV, Za\u00e7e D, Compagno M, Colagrossi L, Santoro MM, Andreoni M, Perno CF, Sarmati L. Management of low-level HIV viremia during antiretroviral therapy: Delphi consensus statement and appraisal of the evidence. Sex Transm Infect. 2024;100(7):442\u20139.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"911_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s12879-025-10940-4","volume":"25","author":"H Yu","year":"2025","unstructured":"Yu H, Yang Y, Cao D, Cao Y, Shi Y, Xiao G, Li P, Feng Y, Wei H, Sun J, et al. Association of HIV low-level viremia with CD4 count recovery among persons living with HIV during antiretroviral therapy in Dehong Prefecture, Southwest China in 2008\u20132021: a longitudinal study. BMC Infect Dis. 2025;25(1):586.","journal-title":"BMC Infect Dis"},{"key":"911_CR42","doi-asserted-by":"publisher","first-page":"663843","DOI":"10.3389\/fimmu.2021.663843","volume":"12","author":"M Younas","year":"2021","unstructured":"Younas M, Psomas C, Reynes C, Cezar R, Kundura L, Portal\u00e8s P, Merle C, Atoui N, Fernandez C, Le Moing V, et al. Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy. Front Immunol. 2021;12:663843.","journal-title":"Front Immunol"},{"issue":"1","key":"911_CR43","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12879-022-07417-z","volume":"22","author":"P Liu","year":"2022","unstructured":"Liu P, You Y, Liao L, Feng Y, Shao Y, Xing H, Lan G, Li J, Ruan Y, Li D. Impact of low-level viremia with drug resistance on CD4 cell counts among people living with HIV on antiretroviral treatment in China. BMC Infect Dis. 2022;22(1):426.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"911_CR44","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/infdis\/jis630","volume":"208","author":"H Hatano","year":"2013","unstructured":"Hatano H, Jain V, Hunt PW, Lee TH, Sinclair E, Do TD, Hoh R, Martin JN, McCune JM, Hecht F, et al. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4\u2009+\u2009T cells. J Infect Dis. 2013;208(1):50\u20136.","journal-title":"J Infect Dis"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00911-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00911-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00911-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:44:31Z","timestamp":1790721871000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00911-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["911"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00911-3","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted following the Helsinki Declaration and was approved by the Human Research Ethics Committee of Guangxi Medical University (Ethical Review No. KY0294), which waived the requirement for informed consent because this was a retrospective analysis of anonymized data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"91"}}